Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

BCBA/ABBVD stock hub

BCBA/ABBVD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/ABBVDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

495.9T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/ABBVD

In the news

Latest news · BCBA/ABBVD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.5

P25 n/aP50 n/aP75 n/a

Trailing P/E99.9

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC22.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/ABBVD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

195

Groups with data

Currency

USD

Showing 195 of 195 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	AR
Employees	57,000
Employees Change	2,000%
Employees Change Percent	3.64
Enterprise value	$584.5T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	$495.9T
Price	$21.01
Price currency	USD
Rev Per Employee	1,522,549,282.81x
Sic	2836
Symbol	bcba/ABBVD
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1%
EV Earnings	117.68x
EV/EBIT	19.18x
EV/EBITDA	13.85x
EV/FCF	21.17x
EV/Sales	6.68x
FCF yield	5.57%
Forward P/E	13.5x
P/B ratio	-54.29x
P/E ratio	99.86x
P/S ratio	5.71x
PE Ratio10 Y	39.99x
PE Ratio3 Y	77.83x
PE Ratio5 Y	56.73x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	34.83%
EBITDA Margin	47.62%
FCF margin	31.81%
Gross margin	72.03%
Gross Profit	$62.5T
Gross Profit Growth	11.06%
Gross Profit Growth Q	15.45%
Gross Profit Growth3 Y	3.97%
Gross Profit Growth5 Y	5.95%
Net Income	$5T
Net Income Growth	-13.35%
Net Income Growth Q	-45.96%
Net Income Growth3 Y	-21.86%
Net Income Growth5 Y	-6.73%
Pretax Margin	9.51%
Profit Margin	5.79%
Profit Per Employee	$87.1M
ROA	10.03
Roa5y	8.68
ROCE	23.19
Roe5y	1,295.2
ROIC	22.24
Roic5y	22.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	9.97%
Cagr3y	14.02%
Div CAGR3	123.41%
EPS Growth	-13.24
EPS Growth Q	-45.83
EPS Growth3 Y	-21.78
EPS Growth5 Y	-6.98
Revenue Growth	9.5x
Revenue Growth Q	12.43x
Revenue Growth3 Y	3.45x
Revenue Growth5 Y	4.59x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.46
Assets	$188.5T
Cash	$13T
Debt	$100.7T
Debt EBITDA	$2.41
Debt FCF	$3.65
Equity	$-9.1T
Interest Coverage	7.52
Liabilities	$197.7T
Net Cash	$-87.8T
Net Cash By Market Cap	$-17.69
Net Debt EBITDA	$2.12
Net Debt FCF	$3.18
Tangible Book Value	$-128.6T
Tangible Book Value Per Share	$-72,800

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.8
Inventory Turnover	3.67
Net Working Capital	$-13.3T
Quick ratio	0.52
Working Capital	$-11.8T

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	64.2%
Dividend Growth Years	5%
Dividend per share	$687
Dividend Years	6
Dividend Yield	3,288.04%
Ex Div Date	2026-04-15
Last Dividend	$237
Payout Frequency	Quarterly
Payout Ratio	325.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	9.97%
200-day SMA	22.08
3Y total return	48.24%
50-day SMA	22.12
50-day SMA vs 200-day SMA	50over200
All Time High	25.96
All Time High Change	-19.49%
All Time High Date	2025-11-27
All Time Low	10.75
All Time Low Change	94.42%
All Time Low Date	2021-09-24
ATR	0.68
Ch YTD	-10.68
High	21.03
High52	25.96
High52 Date	2025-11-27
High52ch	-19.07%
Low	20.88
Low52	17.85
Low52 Date	2025-05-12
Low52ch	17.7%
Ma50ch	-5.53%
Price vs 200-day SMA	-5.33%
RSI	43.15
RSI Monthly	52.87
RSI Weekly	43.6
Sharpe ratio	0.58x
Sortino ratio	1.02
Total Return	3,288%
Tr YTD	-9.48
Tr1m	-1.56%
Tr1w	-4.04%
Tr3m	-6.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$30.2T
Operating Income Growth	15
Operating Income Growth Q	16.6
Operating Income Growth3 Y	0.7
Operating Income Growth5 Y	5.78
Operating margin	34.83

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,763,680,450%
Shares Insiders	0.07%
Shares Institutions	76.02%
Shares Qo Q	0%
Shares Yo Y	0.04%
Short Ratio	3.15

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$26.2T
Average Volume	195.45x
Bv Per Share	-5,204.7
CAPEX	$-1.7T
Ch1m	-2.34
Ch1w	-4.04
Ch1y	7.46
Ch3m	-6.9
Ch3y	37.95
Ch6m	-6.28
Change	-0.19%
Change From Open	0.24
Close	21.05
Days Gap	-0.43
Depreciation Amortization	11,377,732,490,315.8
Dollar Volume	2,269.1
Earnings Date	2026-04-29
EBIT	$30.2T
EBITDA	$41.3T
EPS	$2,805
F Score	7
FCF	$27.6T
FCF EV Yield	4.72x
Financing CF	-14,570,824,993,900
Fiscal Year End	December
Founded	2,012
Income Tax	$3.2T
Investing CF	-8,954,971,803,400
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	$1.05
Lynch Upside	-94.99
Ma150	22.74
Ma150ch	-8.09%
Ma20	21.34
Ma20ch	-2.05%
Net CF	5,824,461,759,200
Open	20.96
P FCF Ratio	17.97
P OCF Ratio	16.91
Payment Date	2026-05-15
Position In Range	86.67
Price Date	2026-05-08
Price EBITDA	$12
Relative Volume	0.55x
Revenue	86,785,309,120,300x
SBC By Revenue	1.57x
Share Based Comp	1,366,317,049,300
Tax By Revenue	3.72x
Tax Rate	39.06%
Tr6m	-5.02%
Volume	108
Z Score	2.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/ABBVD dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+3288.0%

$687 annual per share

Payout ratio

+325.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

5 consecutive years of growth

Total shareholder yield

+3288.0%

Next ex-dividend date: 2026-04-15

Performance

BCBA/ABBVD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/ABBVD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+76.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/ABBVD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.2

Neutral momentum band

Price vs 200-day MA

-5.3%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/ABBVD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/ABBVD stock rating?

bcba/ABBVD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/ABBVD analysis?

The full report lives at /stocks/bcba/ABBVD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/ABBVD?

The latest report frames bcba/ABBVD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/ABBVD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.